Guo Line Advisory Pte LTD Regeneron Pharmaceuticals, Inc. Transaction History
Guo Line Advisory Pte LTD
- $945 Billion
- Q1 2025
A detailed history of Guo Line Advisory Pte LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Guo Line Advisory Pte LTD holds 56,300 shares of REGN stock, worth $35.7 Million. This represents 3.78% of its overall portfolio holdings.
Number of Shares
56,300
Previous 46,360
21.44%
Holding current value
$35.7 Million
Previous $33 Billion
8.13%
% of portfolio
3.78%
Previous 3.41%
Shares
4 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
86.6MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.89 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.36 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.48 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.06 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $68B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...